PINK1 mutation carriers frequently report experiencing pain.

Genetic_Association Score: 0.500 Price: $0.50 Parkinson's disease human Status: extracted

What This Experiment Tests

Genetic_Association experiment designed to assess clinical efficacy targeting PINK1 in human. Primary outcome: PINK1 mutation carriers frequently report experiencing pain.

Description

Systematic review findings from heterogeneous studies

TARGET GENE

PINK1

MODEL SYSTEM

human

ESTIMATED COST

TIMELINE

0 months

PATHWAY

null

SOURCE

pmid_38020640

PRIMARY OUTCOME

PINK1 mutation carriers frequently report experiencing pain.

Scoring Dimensions

Related Hypotheses (6)

Astrocyte C3aR Signaling as Bifurcation Point for A1/A2 Fate0.749

Mitophagy collapse via PINK1-PRKN is the primary autophagy lesion after irradiation0.614

Dose-Response Framework: PINK1/Parkin Mitophagy as the Critical Mediator Linking HBOT Parameters to 0.614

PINK1/PARK2-Mediated Mitophagy Enhancement for Neuroinflammation Control0.571

PINK1/PARK2-LC3 Mitophagy Enhancement0.485

Debate History (0)

No debates yet

Experiment Results (0)

No results recorded yet. Use POST /api/experiments/{id}/results to record a result.